Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial.

British journal of cancer·2022
Same author

Vascular findings on FDG PET/CT.

The British journal of radiology·2020
Same author

Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.

British journal of cancer·2020
Same author

ICORG 06-35: a prospective evaluation of PET-CT scan in patients with non-operable or non-resectable non-small cell lung cancer treated by radical 3-dimensional conformal radiation therapy: a phase II study.

Irish journal of medical science·2019
Same author

First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma.

American journal of medical genetics. Part A·2019
Same author

High grade follicular lymphoma in a patient receiving adalimumab and methotrexate for pityriasis rubra pilaris.

The Journal of dermatological treatment·2017
Same journal

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Correction to: [¹⁸F]PSMA-1007 and [¹⁸F]FDG PET/CT in patients with metastatic triple-negative breast cancer: a prospective head-to-head comparison and assessment of PSMA-targeted radioligand therapy applicability.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

MRI-based perfusion-diffusion habitat analysis for characterizing intratumoral heterogeneity in rectal adenocarcinoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Survival prediction of <sup>18</sup>F-FDG PET/CT in pediatric patients with recurrent neuroblastoma.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

Can brain-to-tumour outer interface radiomics improve the efficiency of MRI in predicting the brain invasion of meningiomas?

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same journal

O-RADS for assessment of adnexal lesions: current status, challenges and future directions.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Multiple myeloma.

Conor D Collins1

  • 1St Vincent's University Hospital, Elm Park, Dublin 4, Ireland. c.collins@st-vincents.ie

Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|February 18, 2010
PubMed
Summary
This summary is machine-generated.

Recent advancements in multiple myeloma imaging and treatment necessitate a combined understanding for optimal patient management. This review covers the current status of both diagnostic and therapeutic strategies.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Related Experiment Videos

Last Updated: Jun 16, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Area of Science:

  • Hematology
  • Medical Imaging
  • Oncology

Background:

  • Multiple myeloma diagnosis and treatment have seen significant evolution.
  • Effective management requires integrating diagnostic and therapeutic progress.

Purpose of the Study:

  • To summarize the current state of multiple myeloma imaging and treatment.
  • To emphasize the synergy between imaging and treatment for optimal patient outcomes.

Main Methods:

  • Review of recent scientific literature on multiple myeloma imaging techniques.
  • Analysis of current therapeutic strategies for multiple myeloma.
  • Synthesis of findings to highlight the interplay between diagnosis and treatment.

Main Results:

  • Significant progress has been made in both imaging modalities and treatment protocols.
  • Advanced imaging aids in precise diagnosis, staging, and monitoring of multiple myeloma.
  • Novel therapeutic approaches have improved patient survival and quality of life.

Conclusions:

  • An integrated approach combining state-of-the-art imaging and contemporary treatments is crucial.
  • Understanding the advancements in both fields is essential for personalized and effective multiple myeloma management.